Table 2. Descriptive analysis of COVID-19 infected patients who resided in two TB sanatoria.
N (%).
| TB patients
(n=104) |
Non-TB patients
(n=57) |
p-value | |
|---|---|---|---|
| Active screening | 72/104 (69.2) | 27/57 (47.4) | 0.006 |
| Ct value (SARS2 N gene) at diagnosis | 18.5 (16.1-32.3) | 18.8 (15.1-30.0) | 0.47 |
| Signs and symptoms of COVID-19 infection | (n=156) | ||
| Fever | 38/101 (37.6) | 37/55 (67.3) | <0.0001 |
| Respiratory system | 80/101 (79.2) | 43/55 (78.2) | 0.88 |
| Gastrointestinal system | 2/101 (2.0) | 6/55 (11.1) | 0.02 |
| Musculoskeletal system | 50/101 (49.5) | 30/55 (54.6) | 0.55 |
| Loss of smell | 10/101 (9.9) | 7/55 (12.7) | 0.60 |
| Loss of taste | 24/101 (23.8) | 24/55 (43.6) | 0.01 |
| Case classification at time of COVID-19 diagnosis (n=157) | <0.001 | ||
| Asymptomatic | 11/102 (10.8) | 9/55 (16.4) | |
| Mild symptoms with no risk factors | 49/102 (48.0) | 41/55 (74.6) | |
| Mild symptoms with risk factors | 39/102 (38.2) | 5/55 (9.1) | |
| Symptomatic with severe pneumonia | 3/102 (2.9) | 0/55 (0) | |
| Worst clinical severity during the course of COVID infection (n=155) | 0.64 | ||
| Asymptomatic | 17/100 (17.0) | 10/55 (18.2) | |
| Mild/Moderate | 77/100 (77.0) | 44/55 (78.2) | |
| Severe | 6/100 (6.0) | 1/55 (3.6) | |
| Laboratory investigation at baseline | |||
| Conducted | 58/101 (57.4) | 6/55 (10.9) | |
| Abnormal Complete Blood Count | 33/58 (56.9) | 1/6 (16.7) | <0.001 |
| C-Reactive Protein grading (n=60) | 1.00 | ||
| Normal (<8 mg/L) | 30/55 (54.6) | 3/5 (60.0) | |
| Grade I (8-20mg/L) | 11/55 (20.0) | 1/5 (20.0) | |
| Grade II (21-40mg/L) | 7/55 (12.7) | 1/5 (20.0) | |
| Grade III (>40mg/L) | 7/55 (12.7) | 0/5 (0) | |
| Treatment (n=156) | |||
| Antibiotics | 13/101 (12.9) | 3/55 (5.5) | |
| Anticoagulant | 2/101 (2.0) | 3/55 (5.5) | |
| Antiviral | 10/101 (9.9) | 1/55 (1.8) | |
| Systemic steroid | 6/101 (5.9) | 2/55 (3.5) | |
| Oxygen therapy | 5/101 (5.0) | 0/55 (0) | |
| Outcomes of COVID-19 infection (n=161) | 0.58 | ||
| Fully recovered | 103/104 (99.0) | 56/57 (99.0) | |
| Recovered with sequels | 0/104 (0) | 0/57 (0) | |
| Death | 1/104 (1.0) | 0/57 (0) | |
| Loss to contact | 0/104 (0) | 1 */57 (1.0) | |
P-values were derived by either Fisher’s exact test or Mann-Whitney’s U test. *One COVID-19 positive case from non-TB patient group (caretaker to TB patient) has left for home inside Myanmar. She was well on last contact with the clinic a week after abscondment.